Which obese youth are at increased risk for type 2 diabetes? Latent class analysis and comparison with diabetic youth

Pediatric Diabetes

Volumn 13, Issue 2, 2012, Pages 181-188

  Greig, Fenella ^a   Hyman, Sharon ^a   Wallach, Elizabeth ^a   Hildebrandt, Tom ^a   Rapaport, Robert ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

ADA; Body mass index z score; Family history of type 2 diabetes; FPG; Homeostasis model assessment of insulin resistance; IFG; IGT; LCA; NHANES 3; OB; Obese youth; OGTT; Type 2 diabetes

Indexed keywords

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CHILDHOOD DISEASE; DISEASE ASSOCIATION; ETHNICITY; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HIGH RISK POPULATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JUVENILE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PUBERTY; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; RETROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 84857508170     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2011.00792.x     Document Type: Article

References (38)

1. American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics 2000: 105: 671-680.
2. Fagot-Campagna A, Saaddine JB, Engelgau MM. Is testing in children for type 2 diabetes a lost battle? Diabetes Care 2000: 23: 1442-1443.
3. Ogdon CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among children and adolescents, 1999-2000. JAMA 2002: 288: 1728-1732.
4. Ogdon CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA 2008: 299: 2401-2405.
5. Pinhas-Hamel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005: 146: 693-700.
6. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002: 346: 393-403.
7. Gomez-Diaz R, Aguilar-Salinas CA, Moran-Villota S et al. Lack of agreement between the revised criteria of impaired fasting glucose and impaired glucose tolerance in children with excess body weight. Diabetes Care 2004: 27: 2229-2233.
8. Weigensberg MJ, Ball GDC, Shaibi GQ, Cruz ML, Goran MI. Decreased B-cell function in overweight Latino children with impaired fasting glucose. Diabetes Care 2005: 28: 2519-2524.
9. Dolan LM, Bean J, D'Alessio D et al. Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents. J Pediatr 2005: 146: 751-758.
10. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes: do we need the oral glucose tolerance test? Ann Intern Med 2002: 136: 575-581.
11. Diabetes Prevention Program Research Group. Strategies to identify adults at high risk for type 2 diabetes. Diabetes Care 2005: 28: 138-144.
12. Schmidt MI, Duncan BB, Bang H et al. Identifying individuals at high risk for diabetes. Diabetes Care 2005: 28: 2013-2018.
13. Sinha R, Fisch G, Teague B et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002: 346: 802-810.
14. Weiss R, Taksali SE, Tamborlane WV, Burget TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005: 28: 902-909.
15. Kaufman FR. Screening for abnormalities of carbohydrate metabolism in teens. J Pediatr 2005: 146: 721-723.
16. Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants in insulin resistance among US adolescents. Diabetes Care 2006: 29: 2427-2432.
17. Gungor N, Saad R, Janorsky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 2004: 144: 47-55.
18. Matthews DR, Hosker JP, Rudinsky AS, Naylor BA, Treacher DF, Turner RG. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985: 28: 412-419.
19. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004: 27: 1487-1495.
20. Levy-Marchal C, Arslanian S, Cutfield W et al. Insulin resistance in children: consensus, perspective and future directions. J Clin Endocrinol Metab 2010: 95: 5189-5198.
21. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al. CDC growth charts: United States. Adv Data 2000: 314: 1-27.
22. American Diabetes Association Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003: 26: 3160-3167.
23. Vermunt JK, Magison J. Latent class cluster analysis. In: Hagenaars JA, McCutcheon AL, eds. Applied Latent Class Analysis. Cambridge, UK: Cambridge University Press, 2002: 89-106.
24. Seiffge-Krenke I, Stemmler M. Coping with everyday stress and links to medical and psychological adaptation in diabetic adolescents. J Adol Health 2003: 33: 180-188.
25. Spycher BD, Silverman M, Brooke AM, Minder CE, Kuehni CE. Distinguishing phenotypes of childhood wheeze and cough using latent class analysis. Eur Respir J 2008: 31: 974-981.
26. Muthen LK, Muthen B. Mplus Users Guide. Los Angeles, CA: Muthen and Muthen, 2004.
27. Schwartz G. Estimating the dimension of a model. Ann Stat 1978: 6: 461-464.
28. Aikaike H. Factor analysis and AIC. Psychometrika 1987: 52: 317-322.
29. Puri M, Freeman K, Garcia G, Nussbaum H, DiMartino-Nardi JR. Criteria for oral glucose tolerance testing of obese minority youth. J Pediatr Endocrinol Metab 2007: 20: 703-709.
30. Fagot-Campagna A, Pettitt DJ, Engelgau MM et al. Type 2 diabetes among North American children and adolescents: an epidemiological review and a public health perspective. J Pediatr 2000: 136: 664-673.
31. Goran MI, Bergman RN, Avila Q et al. Impaired glucose tolerance and reduced β-cell function in overweight Latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab 2004: 98: 207-212.
32. Ball GDC, Huang TK, Gower BA et al. Longitudinal changes in insulin sensitivity, insulin secretion, and β-cell function during puberty. J Pediatr 2006: 148: 16-22.
33. Euling SY, Herman-Giddens ME, Lee PA et al. Examination of US puberty-timing data from 1940-1994 for secular trends: panel findings. Pediatrics 2008: 121 (Suppl. 3): S172-S191.
34. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002: 87: 1017-1023.
35. American Diabetes Association. Prevention or delay of type 2 diabetes (Position Statement). Diabetes Care 2004: 27 (Suppl. 1): S47-S54.
36. Qureshi N, Kai J. Informing patients of familial diabetes mellitus risk: how do they respond? A cross-sectional survey. BMC Health Serv Res 2008: 8: 37.
37. Marcovina S, Bowsher RR, Miller WG et al. Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem 2007: 53: 711-716.
38. Cohen RM, Haggerty S, Herman WH. HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? J Clin Endocrinol Metab 2010: 95: 5203-5206.